CSIMarket Company Name, Ticker, Suppliers, else..
 
Upstream Bio Inc   (NASDAQ: UPB)
 
Price: $6.5500 $-0.07 -1.057%
Day's High: $6.71999979019165 Week Perf: -8.13 %
Day's Low: $ 6.50 30 Day Perf: 2.02 %
Volume (M): 476,485 52 Wk High: $ 33.68
Volume (M$): $ 0 52 Wk Avg: $15.42
Open: $6.58 52 Wk Low: $5.85



 Market Capitalization (Millions $) 356
 Shares Outstanding (Millions) 54
 Employees 75
 Revenues (TTM) (Millions $) 3
 Net Income (TTM) (Millions $) -157
 Cash Flow (TTM) (Millions $) 25
 Capital Exp. (TTM) (Millions $) 0

Business Description


The company is a clinical-stage biopharmaceutical firm developing verekitug, its sole product candidate, for the treatment of severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. It is conducting clinical trials, pursuing regulatory approvals, and preparing for the commercialization of verekitug. The company faces risks related to funding, development, and regulatory processes.


   Company Address: 890 Winter Street Waltham 2451 MA
   Company Phone Number: 208-2466   Stock Exchange / Ticker: NASDAQ UPB


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Announcement

Upstream Bios Steady Ascent Accelerated Clinical Insights and Strong Financial Trajectory in Q1 2025

Published Tue, May 6 2025 11:41 AM UTC

In the rapidly evolving world of biotech, Upstream Bio has made significant strides as it recently reported its first-quarter financial results for 2025. The announcement not only highlights robust financial performance but also underscores an accelerated guidance on its clinical programs, affirming the company s commitment to innovation in precision medicine. Financial Perf...
Equity Market Information

Upstream Bio to Join Russell 2000 Index Amid Market Performance Challenges

Published Sun, Dec 29 2024 8:15 PM UTC

In a significant milestone, Upstream Bio Inc. (Nasdaq: UPB) has announced that it will be added to the Russell 2000 Index, effective at the open of the U.S. equities market on Monday, December 23. This inclusion marks a noteworthy achievement for the biopharmaceutical company, which has been striving to expand its footprint in the competitive market.The Russell 2000 Index, w...
Shares

Upstream: A Strategic Leap in Market Capitalization with $293 Million IPO

Published Tue, Oct 15 2024 8:15 PM UTC

On a pivotal day in capital markets, Upstream, a burgeoning player in the technology sector, announced the successful concluding of its upsized Initial Public Offering (IPO), garnering an impressive $293 million. The IPO not only met analysts expectations but surpassed them with the full exercise of the underwriters’ option to purchase additional shares, underscoring robu...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 107.13
Price to Sales (Expected) -
Price to Book 1.17
PEG (TTM) -

Financial Strength Current
Quick Ratio 21.55
Working Capital Ratio 23.14
Leverage Ratio (MRQ) 0.05
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -2.91 $
Revenues (TTM) 0.06 $
Cash Flow (TTM) 0.47 $
Cash 5.42 $
Book Value 5.6 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 44,293
Net Income per Employee (TTM) -2,090,187
Receivable Turnover Ratio (TTM) 4
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.01

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -4218.09 %
Net Margin (MRQ) -3925.63 %
Net Cash Flow Margin (MRQ) -469.44 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Upstream Bio Inc's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.